Search results
Showing 691 to 705 of 1372 results for social care
Dupilumab for treating moderate to severe atopic dermatitis (TA534)
Evidence-based recommendations on dupilumab (Dupixent) for treating moderate to severe atopic dermatitis in adults.
positive' approach in care homes:- What is the effectiveness and acceptability of different strategies to enable positive risk-taking in...
Recommendation ID NG58/5 Question Care pathway:- In the UK, what is the optimal care pathway for young people and adults...
Highly specialised technologies evaluation committee members
Biographies for each member of the highly specialised technologies evaluation committee.
This guideline covers how to improve the health and wellbeing of employees, with a focus on organisational culture and the role of line managers.
Find out more about the NICE technology appraisal advisory committee B members and their registered interests
role of primary care in supporting young people discharged from children's services:- What are the most effective ways for primary...
NICE has developed a medtech innovation briefing (MIB) on RT300 for spinal cord injury rehabilitation .
Appraisal is the process of determining which records have continuing business or historical value from those which have no further value and should be disposed of appropriately.
Recommendation ID NG74/4 Question Dementia care:- How effective and cost effective is intermediate care including...
Carers:- In what context is it cost effective to increase uptake of flu vaccination among carers?
This key target group can be difficult to identify, and people who provide care may not always identify themselves as carers. The...
research, see the rationale section on assessment and care by healthcare professionals and social care practitioners. Full...
residential care:- What factors (including service organisation and management, staff composition, training andsupervision, and the...
Patisiran for treating hereditary transthyretin amyloidosis (HST10)
Evidence-based recommendations on patisiran (Onpattro) for treating hereditary transthyretin amyloidosis in adults with stage 1 and stage 2 polyneuropathy.
Evidence-based recommendations on durvalumab (Imfinzi) for locally advanced unresectable non-small-cell lung cancer after platinum-based chemoradiation in adults.